Barclays Maintains Pacific Biosciences of California (PACB) Equal-Weight Recommendation
Fintel reports that on September 29, 2023, Barclays maintained coverage of Pacific Biosciences of California (NASDAQ:PACB) with a Equal-Weight recommendation.
Trending
Symbol | Last Price | Change | % Change |
---|---|---|---|